Live Feed:New episodes, highlights, and rapid recaps
Matchups
•18:13 •S2E137

Stem Cell Therapy for Autism: Hope, Evidence & Informed Consent | BetterStem Founder, Greice Murphy

0:00 / 18:13

Game plan

Can stem cell therapy help children with autism, and how should parents evaluate treatments that remain investigational?

In this INCHSTONES Podcast conversation, Sarah Kernion welcomes Greice Murphy, Founder and CEO of BetterSTEM, to explore stem cell therapy for autism, regenerative medicine, informed consent, and the responsibility of balancing parental hope with scientific evidence.

Together, they discuss:

Why stem cell treatments for autism remain investigational and are not FDA-approved

What parents should understand when outcomes cannot be guaranteed

The importance of rigorous clinical trials, baseline assessments, and measurable outcomes

How parent observations can inform assessments of quality of life

The ethical responsibility to communicate uncertainty and avoid unsupported promises

BetterSTEM's approach to individualized evaluation and family support

For families navigating profound autism and nonspeaking autism, curiosity about emerging science deserves both compassion and scientific rigor.

Hope should inspire research. Evidence should guide decisions. Transparency should never be optional.

Explore more at www.inchstonespodcast.com.

Greice Murphy is the Founder and CEO of BetterStem, a pioneering company focused on advancing personalized medicine and investigational stem cell therapies for children with autism. Born in Brazil, her passion for autism care began with her cousin Raul, inspiring a lifelong mission to improve access to innovative healthcare. An award-winning entrepreneur and EY Entrepreneur of the Year, Greice previously founded Advanced Care Partners, one of America's largest pediatric home healthcare providers. She also owns Miami Stem Cell. Through BetterStem, Greice is redefining autism care with a physician-led, whole-child approach that explores underlying biological factors beyond symptoms and behaviors.

Chapters

Key Takeaways

  • Stem cell treatments for autism remain investigational and are not FDA-approved.
  • The episode emphasizes rigorous clinical trials, baseline assessments, and measurable outcomes when evaluating treatments.
  • Parents’ observations can help inform assessments of quality of life, while outcomes cannot be guaranteed.
  • The discussion highlights the ethical importance of communicating uncertainty and avoiding unsupported promises.
  • BetterStem is described as offering individualized evaluation and family support through a physician-led, whole-child approach.

Frequently Asked Questions

Are stem cell treatments for autism FDA-approved?

No. The show notes state that they remain investigational and are not FDA-approved.

What should parents consider when evaluating investigational treatments?

Consider the evidence, clinical trials, baseline assessments, measurable outcomes, and the fact that outcomes cannot be guaranteed.

How can parents contribute to quality-of-life assessments?

Their observations can inform assessments of quality of life.

Who is Greice Murphy?

She is the Founder and CEO of BetterStem and previously founded Advanced Care Partners.